Skip to content
healthcare.dev

calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / potassium chloride 0.537 MEQ Oral Tablet [Medi-Lyte]

RxNorm concept 1090849, branded drug (sbd). Prescribable name: Medi-Lyte 0.537 MEQ / 0.132 MEQ / 0.107 MEQ Oral Tablet.

RxCUI
1090849
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1090849 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Medi-Lyte (calcium phosphate 18 MG / magnesium carbonate 9 MG / potassium chloride 40 MG) Oral Tablet; calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / K+ Chloride 0.537 MEQ Oral Tablet [Medi-Lyte]; calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / Pot Chloride 0.537 MEQ Oral Tablet [Medi-Lyte]

Related concepts

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1090849 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1090849 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1090849. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.